IDIOTYPIC VACCINE

The invention concerns the use of recombinant clonotypic immunoglobulins (Ig) as a vaccine in the treatment of HCV-related and non HCV-related lymphoproliferations, in particular the use of recombinant proteins with immunogenic properties derived from protein segments VK3-20 and VK3-15 of Ig light c...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: DOLCETTI, RICCARDO, GUIDOBONI, MASSIMO, NOLLI, MARIA LUISA, DE RE, VALLI, GASPAROTTO, DANIELA, CASTIGLIONI, SONIA
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator DOLCETTI, RICCARDO
GUIDOBONI, MASSIMO
NOLLI, MARIA LUISA
DE RE, VALLI
GASPAROTTO, DANIELA
CASTIGLIONI, SONIA
description The invention concerns the use of recombinant clonotypic immunoglobulins (Ig) as a vaccine in the treatment of HCV-related and non HCV-related lymphoproliferations, in particular the use of recombinant proteins with immunogenic properties derived from protein segments VK3-20 and VK3-15 of Ig light chains derived from patients with lymphoproliferations. L'invention concerne l'utilisation d'immunoglobulines (Ig) clonotypiques recombinantes en tant que vaccin pour le traitement de lymphoproliférations liées au VHC ou non liées au VHC, en particulier l'utilisation de protéines recombinantes ayant des propriétés immunogènes dérivées des segments de protéine VK3-20 et VK3-15 des chaînes légères d'Ig dérivées de patients présentant des lymphoproliférations.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2009016456A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2009016456A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2009016456A23</originalsourceid><addsrcrecordid>eNrjZBD0dPH0D4kM8HRWCHN0dvb0c-VhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHh_kYGBpYGhmYmpmaORsbEqQIAlsgesw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>IDIOTYPIC VACCINE</title><source>esp@cenet</source><creator>DOLCETTI, RICCARDO ; GUIDOBONI, MASSIMO ; NOLLI, MARIA LUISA ; DE RE, VALLI ; GASPAROTTO, DANIELA ; CASTIGLIONI, SONIA</creator><creatorcontrib>DOLCETTI, RICCARDO ; GUIDOBONI, MASSIMO ; NOLLI, MARIA LUISA ; DE RE, VALLI ; GASPAROTTO, DANIELA ; CASTIGLIONI, SONIA</creatorcontrib><description>The invention concerns the use of recombinant clonotypic immunoglobulins (Ig) as a vaccine in the treatment of HCV-related and non HCV-related lymphoproliferations, in particular the use of recombinant proteins with immunogenic properties derived from protein segments VK3-20 and VK3-15 of Ig light chains derived from patients with lymphoproliferations. L'invention concerne l'utilisation d'immunoglobulines (Ig) clonotypiques recombinantes en tant que vaccin pour le traitement de lymphoproliférations liées au VHC ou non liées au VHC, en particulier l'utilisation de protéines recombinantes ayant des propriétés immunogènes dérivées des segments de protéine VK3-20 et VK3-15 des chaînes légères d'Ig dérivées de patients présentant des lymphoproliférations.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2009</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20090205&amp;DB=EPODOC&amp;CC=WO&amp;NR=2009016456A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20090205&amp;DB=EPODOC&amp;CC=WO&amp;NR=2009016456A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DOLCETTI, RICCARDO</creatorcontrib><creatorcontrib>GUIDOBONI, MASSIMO</creatorcontrib><creatorcontrib>NOLLI, MARIA LUISA</creatorcontrib><creatorcontrib>DE RE, VALLI</creatorcontrib><creatorcontrib>GASPAROTTO, DANIELA</creatorcontrib><creatorcontrib>CASTIGLIONI, SONIA</creatorcontrib><title>IDIOTYPIC VACCINE</title><description>The invention concerns the use of recombinant clonotypic immunoglobulins (Ig) as a vaccine in the treatment of HCV-related and non HCV-related lymphoproliferations, in particular the use of recombinant proteins with immunogenic properties derived from protein segments VK3-20 and VK3-15 of Ig light chains derived from patients with lymphoproliferations. L'invention concerne l'utilisation d'immunoglobulines (Ig) clonotypiques recombinantes en tant que vaccin pour le traitement de lymphoproliférations liées au VHC ou non liées au VHC, en particulier l'utilisation de protéines recombinantes ayant des propriétés immunogènes dérivées des segments de protéine VK3-20 et VK3-15 des chaînes légères d'Ig dérivées de patients présentant des lymphoproliférations.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2009</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZBD0dPH0D4kM8HRWCHN0dvb0c-VhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHh_kYGBpYGhmYmpmaORsbEqQIAlsgesw</recordid><startdate>20090205</startdate><enddate>20090205</enddate><creator>DOLCETTI, RICCARDO</creator><creator>GUIDOBONI, MASSIMO</creator><creator>NOLLI, MARIA LUISA</creator><creator>DE RE, VALLI</creator><creator>GASPAROTTO, DANIELA</creator><creator>CASTIGLIONI, SONIA</creator><scope>EVB</scope></search><sort><creationdate>20090205</creationdate><title>IDIOTYPIC VACCINE</title><author>DOLCETTI, RICCARDO ; GUIDOBONI, MASSIMO ; NOLLI, MARIA LUISA ; DE RE, VALLI ; GASPAROTTO, DANIELA ; CASTIGLIONI, SONIA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2009016456A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2009</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>DOLCETTI, RICCARDO</creatorcontrib><creatorcontrib>GUIDOBONI, MASSIMO</creatorcontrib><creatorcontrib>NOLLI, MARIA LUISA</creatorcontrib><creatorcontrib>DE RE, VALLI</creatorcontrib><creatorcontrib>GASPAROTTO, DANIELA</creatorcontrib><creatorcontrib>CASTIGLIONI, SONIA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DOLCETTI, RICCARDO</au><au>GUIDOBONI, MASSIMO</au><au>NOLLI, MARIA LUISA</au><au>DE RE, VALLI</au><au>GASPAROTTO, DANIELA</au><au>CASTIGLIONI, SONIA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>IDIOTYPIC VACCINE</title><date>2009-02-05</date><risdate>2009</risdate><abstract>The invention concerns the use of recombinant clonotypic immunoglobulins (Ig) as a vaccine in the treatment of HCV-related and non HCV-related lymphoproliferations, in particular the use of recombinant proteins with immunogenic properties derived from protein segments VK3-20 and VK3-15 of Ig light chains derived from patients with lymphoproliferations. L'invention concerne l'utilisation d'immunoglobulines (Ig) clonotypiques recombinantes en tant que vaccin pour le traitement de lymphoproliférations liées au VHC ou non liées au VHC, en particulier l'utilisation de protéines recombinantes ayant des propriétés immunogènes dérivées des segments de protéine VK3-20 et VK3-15 des chaînes légères d'Ig dérivées de patients présentant des lymphoproliférations.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_WO2009016456A2
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title IDIOTYPIC VACCINE
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T09%3A48%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DOLCETTI,%20RICCARDO&rft.date=2009-02-05&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2009016456A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true